IMPLANTABLE CLIP

K100090 · Genicon · FZP · Feb 2, 2010 · General, Plastic Surgery

Device Facts

Record IDK100090
Device NameIMPLANTABLE CLIP
ApplicantGenicon
Product CodeFZP · General, Plastic Surgery
Decision DateFeb 2, 2010
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 878.4300
Device ClassClass 2
AttributesTherapeutic

Intended Use

The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing.

Device Story

Titanium ligation clips used for hemostasis and tissue approximation during surgical procedures. Clips are supplied in various sizes (mini-micro to extra large) on disposable holders. Device is applied by surgeons to close vessels or connect internal tissues to facilitate healing. Titanium material provides biocompatibility for long-term implantation. Device functions as a mechanical fastener; no electronic or software components.

Clinical Evidence

No clinical data. Substantial equivalence is based on established material safety (titanium) and historical clinical acceptance of titanium ligation clips since the 1960s.

Technological Characteristics

Material: Grade I Titanium per ASTM F-67 95 and ISO 5832-2-93. Form factor: Sterile, disposable clips in various sizes (mini-micro to extra large) on disposable holders. Mechanical ligation principle. Manufactured per GMP, AAMI, and ISO 13485 standards.

Indications for Use

Indicated for use in surgical procedures requiring approximation of soft tissue or ligation of vessels and structures to achieve hemostasis or tissue connection.

Regulatory Classification

Identification

An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K100090 FEB - 2 2010 ## 510(k) Summary Statement Submitters Name: GENICON 6869 Sta Point Court Suite #114 Winter Park, FL 32792 Ph: 1.321.297.1189 Fx: 1.407.679.0880 Contact Name: Melanie Murphy Name of Device: Titanium Ligation Clip Safety & Effectiveness Data Summary: Classification Name: Clip, Implantable Common/Usual Name: Ligation Clip Proprietary Name: n/a at this time Classification: Class II | Implantable Clip: | #79 FZP | | |-------------------|---------|------------------------------------------------------------------------------------------------------------------------| | Hemostatic Clip: | | #79 MCH Reg. #878.4300 - 36-2 - 1. 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 " " " " " " " " " " " " " " " " " " " " " " " " " " | Performance Standards: Devices are manufactured according to Good Manufacturing Practices (G.M.P.), Association for Advancement of Medical Instrumentation (A.A.M.I.) and American Society for Testing and Materials (A.S.T.M.) requirements and applicable Harmonized Standards ISO 13485. Material Composition: A.S.T.M F-67 95, Grade I Titanium I.S.O. #5832-2-93, Grade I Titanium Intended Use: The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing. Device Description: The ligation clips are composed exclusively of titanium, and are supplied as sterile products in various sizes (mini-micro, micro, smallmedium, medium, medium-large, large and extra large) with six clips per disposable holder. The titiaum used meets all requirements for A.S.T.M. specifications F-67 95 "Unalloyed Titanium for Surgical Implant Applications", Grade I and ISO 5832-2-93 and 10993 "Implants for Surgery - Metallic Materials - Part 2: Unalloyed Titanium". Predicate Devices: Ethicon K830503 {1}------------------------------------------------ Comparison of Technological Characteristics: The titanium clip material and disposable holder material substantially equivalent to the predicate device. In function, the clips are the substantially equivalent to the predicate device as well. ﻣﺎ ﺟ ( Safety and Efficacy Information: Titanium is well recognized as being safe and effective for long term implantation. Millions of titanium clips are applied yearly and since inception in the 1960's attest to the wide acceptance of this method of hemostatic and ligation control. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA". Inside the circle is an abstract emblem resembling an eagle or a stylized human figure, composed of three curved lines. The emblem is positioned to the right of the text. ## Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002 FEB - 2 2010 Genicon % Mr. Gary W. Haberland President 6869 Stapoint Court #114 Winter Park, Florida 32792 Re: K100090 Trade/Device Name: Genicon Ligation Clip Regulation Number: 21 CFR 878,4300 Regulation Name: Implantable clip Regulatory Class: Class II Product Code: FZP, MCH Dated: January 08, 2010 Received: January 12, 2010 Dear Mr. Haberland: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 {3}------------------------------------------------ Page 2 - Mr. Gary W. Haberland CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.lyfm Sincerely yours, Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 12,100090 510(k): Section 4 - Indications for Use ·Device Name: GENICON Ligation Clip Indications for Use: The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing. - Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) Page 1 of (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) 00090 Daniel Keene for MXM (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...